Kursprognose für Processa Pharmaceuticals Inc (PCSA)PCSAProcessa Pharmaceuticals Inc

Alphio's PCSA stock price prediction model matches the current Processa Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.92 (+2.37%). The 1-week path is $1.91 (+1.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Processa Pharmaceuticals Inc (PCSA) is currently trading at $1.88, significantly down from its 52-week high of $8.88, indicating a 78.21% decline over the past year. The RSI is at 61.154, suggesting it is nearing overbought territory, which could limit short-term upside. Although there has been insider buying totaling about $40,000, the stock fell 38% after announcing a $200 million acquisition, reflecting market skepticism. The main risk is the company's negative earnings trend, with an EPS of -1.75 reported recently, indicating ongoing financial struggles.

Processa Pharmaceuticals Inc (PCSA) last closed at $1.8801, gaining +2.18%. These facts feed the 1-day and 1-week PCSA price prediction above.